Regularly updated material to support the introduction of adalimumab, eculizumab, natalizumab, ranibizumab and tocilizumab biosimilars.
Resources to support the choice of eculizumab biosimilar within organisations.
Resources to support the choice of natalizumab biosimilar within organisations.
Resources to specifically support the introduction of ranibizumab biosimilar for ocular use.
Resources to support the choice of tocilizumab biosimilar within organisations.